Gary C. Visor
Plus aucun poste en cours
Profil
Gary C.
Visor worked as a Principal at Cardinal Health, Gilead Sciences, InterMune, Plexxikon, CellGate Technologies LLC, Roche Palo Alto LLC, and Syntex Research Centre.
He also worked as VP-Pharmaceutical Research & Technical Operations at OSI Pharmaceuticals, Inc. Visor holds a doctorate degree from the University of Florida.
Anciens postes connus de Gary C. Visor
| Sociétés | Poste | Fin |
|---|---|---|
Syntex Research Centre
 Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million. | Corporate Officer/Principal | - |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
| GILEAD SCIENCES, INC. | Corporate Officer/Principal | - |
| INTERMUNE INC | Corporate Officer/Principal | - |
CellGate Technologies LLC
 CellGate Technologies LLC Computer PeripheralsElectronic Technology Part of StarVox Communications, Inc., CellGate Technologies LLC is a company that manufactures integrated wireless IP modem adapters and provides wireless services. The company is based in Boca Raton, FL. The company was founded by Edgar G. Engleman. CellGate Technologies was acquired by U.S. Wireless Data, Inc. on November 17, 2000 for $2.23 million. | Corporate Officer/Principal | - |
Formation de Gary C. Visor
| University of Florida | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CARDINAL HEALTH, INC. | Distribution Services |
| GILEAD SCIENCES, INC. | Health Technology |
| Entreprise privées | 6 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
Plexxikon, Inc.
 Plexxikon, Inc. Miscellaneous Commercial ServicesCommercial Services Plexxikon, Inc. provides clinical and medical drug discovery and development services. The company was founded by Joseph P. Schlessinger, Thomas Richard Kassberg, Sung-hou Kim and K. Peter Hirth in 2001 and is headquartered in Berkeley, CA. | Commercial Services |
CellGate Technologies LLC
CellGate Technologies LLC Computer PeripheralsElectronic Technology Part of StarVox Communications, Inc., CellGate Technologies LLC is a company that manufactures integrated wireless IP modem adapters and provides wireless services. The company is based in Boca Raton, FL. The company was founded by Edgar G. Engleman. CellGate Technologies was acquired by U.S. Wireless Data, Inc. on November 17, 2000 for $2.23 million. | Electronic Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
Syntex Research Centre
Syntex Research Centre Pharmaceuticals: OtherHealth Technology Syntex Research Centre is a British company that provides pharmaceutical products. Syntex Research Centre was acquired by Quintiles Scotland Ltd on February 01, 1995 for $20.68 million. | Health Technology |
